Probiotics may reduce risk of VAP in ICU patients

06/17/2010 | Science Blog

Daily probiotic therapy halved the risk of ventilator-associated pneumonia in a select group of patients in the intensive care unit, U.S. researchers found. The study, which used twice-daily doses of Lactobacillus rhamnosus, also showed that the treatment reduced the amount of antibiotics needed after almost five years.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Nutritionist
ABQ Health Partners
Albuquerque, NM
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA